Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 19;10(11):290.
doi: 10.3390/life10110290.

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening

Affiliations
Review

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening

Andreas C Chrysostomou et al. Life (Basel). .

Abstract

The human papillomavirus is one of the most common sexually transmitted viruses, and an infection from this virus may become persistent, leading to diseases such as cervical cancer. In the past, cytology-based methods such as the Papanicolaou (Pap) test were imperative to identify the disease at a stage where it can be treated. However, since the 1980s where the etiological association of HPV and cervical cancer was identified, new tests began emerging directed towards identifying the virus. Furthermore, as the biology of HPV along with the relationships with its host are elucidated, these tests and treatments further advance. Recently in Europe, there is a movement towards the implementation of HPV testing methodologies in national screening programs to precede cytological testing. These screening strategies are recommended by the European guidelines and the World Health Organization. This review presents the current HPV testing methodologies, their application in organized population-based cervical cancer screening programs based on the most recent European guidelines, and their implementation status in countries in Europe.

Keywords: HPV testing; cervical cancer; human papillomavirus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Management algorithm in primary HPV screening. Abnormal cytology refers to a borderline or more severe cytological result. This figure was adapted from Chrysostomou et al. (2018) [15]. This algorithm was developed based on “The supplements of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening of 2015” [27].
Figure 2
Figure 2
The implementation status of primary HPV testing in E.U. member states and some E.U. associated countries. This figure was adapted from Chrysostomou et al. (2018) [15], and it is updated with new information. The magnifying glass serves to enlarge the island of Malta. It is important to state that this is a rapidly changing field and that the status of implementation could not be confirmed for all countries from two independent sources.

Similar articles

Cited by

References

    1. Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin. Cancer Biol. 2014;26:13–21. doi: 10.1016/j.semcancer.2013.11.002. - DOI - PubMed
    1. Bowden S.J., Kyrgiou M. Human papillomavirus. Obstet. Gynaecol. Reprod. Med. 2020;30:109–118. doi: 10.1016/j.ogrm.2020.02.003. - DOI
    1. Vos R.A., Pasmans H., Tymchenko L., Janga-Jansen A.V.A., Baboe-Kalpoe S., Hulshof K., de Melker H.E., van der Klis F.R.M. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands. Vaccine. 2020;38:2816–2826. doi: 10.1016/j.vaccine.2020.02.017. - DOI - PubMed
    1. Moscicki A.-B., Schiffman M., Burchell A., Albero G., Giuliano A.R., Goodman M.T., Kjaer S.K., Palefsky J. Updating the Natural History of Human Papillomavirus and Anogenital Cancers. Vaccine. 2012;30:F24–F33. doi: 10.1016/j.vaccine.2012.05.089. - DOI - PMC - PubMed
    1. Ermel A., Shew M.L., Imburgia T.M., Brown M., Qadadri B., Tong Y., Brown D.R. Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life. Papillomavirus Res. 2018;5:75–79. doi: 10.1016/j.pvr.2018.01.001. - DOI - PMC - PubMed